Clinical Operations Journal by Dx Direct

Diagnostics

Antibiotic stewardship is actually a financial win.

The ROI of Rapid Diagnostics: Can a 10-Minute Test Actually Save You Money? Every unnecessary antibiotic prescription costs more than the price of the medication itself. It can lead to repeat visits, adverse drug reactions, unnecessary laboratory testing, lower patient satisfaction when symptoms persist, and mounting pressure on antibiotic stewardship programs. Add clinician time, overcrowded waiting rooms, and declining reimbursement margins, and the financial impact becomes much larger than most healthcare organizations realize. Urgent care centers and emergency departments face this challenge every day. A patient walks in with fever,

Read More »

Simplifying Point-of-Care Adoption

Supporting better decisions without adding complexity.

FebriDx is intended to support clinical decision-making and must be interpreted in the context of signs, symptoms, patient history, and clinical judgment. It does not identify a specific pathogen and is not a standalone diagnostic.

FebriDx® is manufactured by Lumos Diagnostics. Dx Direct serves as an authorized distribution channel and does not manufacture the product.

© 2026. All Rights Reserved.